News from brainstorm cell therapeutics inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 19, 2020, 07:57 ET BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Outcomes at the Virtual New York Stem Cell Foundation Conference

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced the...


Oct 15, 2020, 08:13 ET BrainStorm Announces Financial Results for the Third Quarter of 2020 and Provides a Corporate Update

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial ...


Oct 12, 2020, 06:00 ET BrainStorm to Present at the 2020 Cell & Gene Meeting on the Mesa

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced...


Oct 02, 2020, 01:00 ET BrainStorm Cell Therapeutics to Announce Third Quarter Financial Results and Provide a Corporate Update

BrainStorm-Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating...


Sep 30, 2020, 05:00 ET BrainStorm Announces Scientific Presentation at the Annual NEALS Meeting

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced the...


Sep 29, 2020, 06:00 ET BrainStorm Appoints William K. White as Senior Vice President, Head of Market Access & Pricing

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today...


Sep 16, 2020, 07:30 ET Brainstorm Announces Grant of a New Japanese Patent for NurOwn®

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced ...


Aug 25, 2020, 07:39 ET BrainStorm to Present Data Linking MRI Measures to Functional Improvement in Progressive Multiple Sclerosis (MS)

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today...


Aug 10, 2020, 07:30 ET BrainStorm to Present at the 40th Annual Canaccord Genuity Growth Conference

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced...


Aug 05, 2020, 07:00 ET BrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate Update

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial ...


Jul 27, 2020, 07:58 ET BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D Update

BrainStorm-Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating...


Jul 08, 2020, 05:31 ET BrainStorm Hosting KOL Webinar to Discuss NurOwn® Phase 2 Alzheimer's Disease Program

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, is hosting a Key...


Jul 02, 2020, 06:49 ET BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today...


Jul 01, 2020, 08:50 ET BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, will hold a Key...


Jun 24, 2020, 07:00 ET BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced a...


Jun 23, 2020, 05:45 ET BrainStorm Cell Therapeutics to Join the Russell 2000® Index and Russell 3000® Index

BrainStorm Cell Therapeutics Inc. (NasdaqCM: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced...


Jun 11, 2020, 07:28 ET BrainStorm to Present at the Raymond James Human Health Innovations Conference

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced...


Jun 09, 2020, 06:00 ET The ALS Association, I AM ALS Award BrainStorm Cell Therapeutics $500,000 for ALS Biomarker Study

The ALS Association and I AM ALS announced today that the organizations have awarded a combined grant of $500,000 to BrainStorm Cell Therapeutics...


Jun 03, 2020, 06:00 ET BrainStorm to Participate in BIO Digital 2020

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced Dr....


Jun 02, 2020, 06:00 ET BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today an ...


May 27, 2020, 07:25 ET BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today...